Aug 4, 2023
January 25, 2025
This week’s newsletter included:
-
2023 MDMA Medical Technology Executive Forum
-
Quansys Biosciences and the Michael J. Fox Foundation Partner to Accelerate Parkinson’s Disease Research
-
Alucent Biomedical Wins FDA Approval for U.S. Clinical Study
-
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
-
Renalytix Forms Clinical Advisory Board
-
Jen Brown Appointed Chair of Department of Entrepreneurship & Strategy
-
Utah Business Best Companies to Work For
-
Salt Lake City Named One of Six Best American Cities for Entrepreneurs
-
Teva Reports Second Quarter 2023 Financial Results
-
BD Reports Third Quarter Fiscal 2023 Financial Results
-
Five O’Clock Podcast: Howard McLeod on the Rising Impact of Genomic Research on Medicine
Recent News
- Purgo Scientific Appoints Veteran MedTech Leader as Chief Executive Officer
- Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
- Improving Women’s Health: MobileODT Joins Liger Medical
- Wasatch Health Announces Structured Capital Fund
- Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
- Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
